ImmPACT Bio to Participate in the 2023 Truist Securities BioPharma Symposium ...Middle East

PR Newswire - News
ImmPACT Bio to Participate in the 2023 Truist Securities BioPharma Symposium
LOS ANGELES, Oct. 30, 2023 /PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune diseases, today announced that it will participate in...

Read More Details
Finally We wish PressBee provided you with enough information of ( ImmPACT Bio to Participate in the 2023 Truist Securities BioPharma Symposium )

Apple Storegoogle play

Also on site :